Bioqual Retained Earnings (Accumulated Deficit) 2010-2024 | BIOQ
Bioqual retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Bioqual Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024 |
$31 |
| 2023 |
$31 |
| 2022 |
$31 |
| 2021 |
$27 |
| 2020 |
$22 |
| 2019 |
$18 |
| 2018 |
$16 |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Bioqual Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-08-31 |
$31 |
| 2024-05-31 |
$31 |
| 2024-02-29 |
$32 |
| 2023-11-30 |
$32 |
| 2023-08-31 |
$32 |
| 2023-05-31 |
$31 |
| 2023-02-28 |
$32 |
| 2022-11-30 |
$33 |
| 2022-08-31 |
$33 |
| 2022-05-31 |
$31 |
| 2022-02-28 |
$29 |
| 2021-11-30 |
$29 |
| 2021-08-31 |
$29 |
| 2021-05-31 |
$27 |
| 2021-02-28 |
$25 |
| 2020-11-30 |
$24 |
| 2020-08-31 |
$24 |
| 2020-05-31 |
$22 |
| 2020-02-29 |
$21 |
| 2019-11-30 |
$20 |
| 2019-08-31 |
|
| 2019-05-31 |
$18 |
| 2019-02-28 |
|
| 2018-11-30 |
|
| 2018-08-31 |
|
| 2018-05-31 |
$16 |
| 2018-02-28 |
|
| 2017-11-30 |
|
| 2017-08-31 |
|
| 2017-05-31 |
|
| 2017-02-28 |
|
| 2016-11-30 |
|
| 2016-08-31 |
|
| 2016-05-31 |
|
| 2016-02-29 |
|
| 2015-11-30 |
|
| 2015-08-31 |
|
| 2015-05-31 |
|
| 2015-02-28 |
|
| 2014-08-31 |
|
| 2014-05-31 |
|
| 2013-11-30 |
|
| 2013-08-31 |
|
| 2013-05-31 |
|
| 2012-05-31 |
|
| 2012-02-29 |
|
| 2011-11-30 |
|
| 2011-08-31 |
|
| 2011-05-31 |
|
| 2011-02-28 |
|
| 2010-11-30 |
|
| 2010-08-31 |
|
| 2010-05-31 |
|
| 2010-02-28 |
|
| 2009-11-30 |
|
| 2009-08-31 |
|
| 2009-05-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.059B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
